Malaisse W J, Ladrière L, Laghmich A, Louchami K, Jijakli H, Viñambres C, Villanueva-Peñacarrillo M L, Valverde I, Björkling F
Laboratory of Experimental Medicine, Brussels Free University, Brussels, Belgium.
Biochem Mol Med. 1997 Oct;62(1):76-84. doi: 10.1006/bmme.1997.2621.
A novel ester of succinic acid, 1,2,3-tri(methylsuccinyl)glycerol ester (3SMG), was found to stimulate insulin release from rat pancreatic islets. In the presence of 7 mM d-glucose, a 10 microM concentration of 3SMG was sufficient to cause a significant increase in insulin output. The ester mimicked the effect of other nutrient secretagogues in enhancing the synthesis of islet peptides, with a preferential action on proinsulin as distinct from nonhormonal peptides, in decreasing 86Rb outflow from prelabeled islets, and in stimulating Ca2+ inflow into the islet cells. It is proposed, therefore, that 3SMG displays the attributes suitable for stimulation or potentiation of insulin release in noninsulin-dependent diabetes, without requiring administration in large amounts and, hence, without the risk of excessive hepatic gluconeogenesis.
一种新型琥珀酸酯,1,2,3-三(甲基琥珀酰基)甘油酯(3SMG),被发现可刺激大鼠胰岛释放胰岛素。在存在7 mM d-葡萄糖的情况下,10 μM浓度的3SMG足以使胰岛素分泌显著增加。该酯在增强胰岛肽合成方面模拟了其他营养促分泌剂的作用,对胰岛素原具有优先作用,与非激素肽不同,可减少预标记胰岛中86Rb的流出,并刺激Ca2+流入胰岛细胞。因此,有人提出,3SMG具有适合在非胰岛素依赖型糖尿病中刺激或增强胰岛素释放的特性,无需大量给药,因此没有肝糖异生过度的风险。